REG - Haleon PLC - Director/PDMR Shareholding

HALEONAnnouncement

05/09/2025 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250905:nRSE2507Ya&default-theme=true

RNS Number : 2507Y  Haleon PLC  05 September 2025

 

 Haleon plc: Director/PDMR Shareholding

 

5 September 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by Persons
Discharging Managerial Responsibilities ("PDMRs").

This notification sets out the details of the grant of Haleon share awards
over Ordinary Shares and American Depositary Shares (ADS) made to PDMRs under
the Haleon Share Value Plan and Performance Share Plan.

The Performance Share Plan (Interim) awards are subject to continued
employment and performance conditions over the performance period ending on 31
December 2027 (vesting in March 2028). Performance targets were disclosed in
the Annual Report and Form 20-F 2024.

The Share Value Plan (Buyout) awards are subject to continued employment.

All awards were made in line with the principles of Haleon's Directors'
Remuneration Policy and are subject to malus and clawback provisions.

 

 1       Details of the person discharging managerial responsibilities / person closely

       associated

 a)      Name                                                             Carl Haney

 2       Reason for the notification

 a)      Position/status                                                  Chief R&D Officer

 b)      Initial notification /Amendment                                  Initial Notification

 3       Details of the issuer, emission allowance market participant, auction

       platform, auctioneer or auction monitor

 a)      Name                                                             Haleon plc

 b)      LEI                                                              549300PSB3WWEODCUP19

 4       Details of the transaction(s): section to be repeated for (i) each type of

       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
         place where transactions have been conducted
 a)      Description of the financial instrument, type of instrument      Ordinary Shares of £0.01 each

         Identification code                                              GB00BMX86B70

 b)      Nature of the transaction                                        (i)           Grant of a conditional award under the Haleon plc

                                                                Performance Share Plan (Interim)

                                                                          (ii)          Grant of a conditional award under the Haleon plc Share
                                                                          Value Plan (Buyout)
 c)      Price(s) and volume(s)

                                                                                                              Price(s)          Volume(s)
                                                                                            (i)               Nil               641,096
                                                                                            (ii)              Nil               192,571

 d)      Aggregated information

         - Aggregated volume                                              833,667

         - Price                                                          Nil

 e)      Date of the transaction                                          4 September 2025

 f)      Place of the transaction                                         Outside a trading venue

 

 

 1       Details of the person discharging managerial responsibilities / person closely

       associated

 a)      Name                                                             Nathalie Gerschtein

 2       Reason for the notification

 a)      Position/status                                                  President North America

 b)      Initial notification /Amendment                                  Initial Notification

 3       Details of the issuer, emission allowance market participant, auction

       platform, auctioneer or auction monitor

 a)      Name                                                             Haleon plc

 b)      LEI                                                              549300PSB3WWEODCUP19

 4       Details of the transaction(s): section to be repeated for (i) each type of

       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
         place where transactions have been conducted
 a)      Description of the financial instrument, type of instrument      Haleon plc American Depositary Shares (ADS)

         Identification code                                              US4055521003

 b)      Nature of the transaction                                        (i)           Grant of a conditional award under the Haleon plc

                                                                Performance Share Plan (Interim)

                                                                          (ii)          Grant of a conditional award under the Haleon plc Share
                                                                          Value Plan (Buyout)
 c)      Price(s) and volume(s)

                                                                                                              Price(s)          Volume(s)
                                                                                            (i)               Nil               244,400
                                                                                            (ii)              Nil               405,911

 d)      Aggregated information

         - Aggregated volume                                              650,311

         - Price                                                          Nil

 e)      Date of the transaction                                          4 September 2025

 f)      Place of the transaction                                         Outside a trading venue

 

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBBGDCRDGDGUU